{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:28:01Z","timestamp":1791268081390,"version":"4.1.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.bbadis.2014.10.013","type":"journal-article","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T14:37:55Z","timestamp":1414420675000},"page":"1145-1154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":306,"title":["Resveratrol and diabetes: from animal to human studies"],"prefix":"10.1016","volume":"1852","author":[{"given":"Tomasz","family":"Szkudelski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Szkudelska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2014.10.013_bb0005","series-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2013"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0010","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.2337\/diacare.29.s1.06.s43","article-title":"Diagnosis and classification of diabetes mellitus","volume":"29","author":"American Diabetes Association","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1503\/cmaj.1031414","article-title":"Oral antihyperglycemic therapy for type 2 diabetes mellitus","volume":"175","author":"Cheng","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/bja\/aer120","article-title":"Diabetes mellitus: new drugs for a new epidemic","volume":"107","author":"Nicholson","year":"2011","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0025","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/pr.110.003319","article-title":"Novel pharmacological approaches to the treatment of type 2 diabetes","volume":"64","author":"Verspohl","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0030","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.biochi.2011.11.001","article-title":"Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and NO bioavailability: Potential benefits to cardiovascular diseases","volume":"94","author":"Frombaum","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0035","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.bbadis.2014.10.016","article-title":"Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases","volume":"1852","author":"Zordoky","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/ERC-13-0171","article-title":"Resveratrol and cancer: focus on in vivo evidence","volume":"21","author":"Carter","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0045","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbadis.2014.11.004","article-title":"Resveratrol and cancer: challenges for clinical translation","volume":"1852","author":"Singh","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0050","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bbadis.2014.12.024","article-title":"Resveratrol and inflammation","volume":"1852","author":"Poulsen","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/156720209787466019","article-title":"Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection","volume":"6","author":"Pall\u00e0s","year":"2009","journal-title":"Curr. Neurovasc. Res."},{"issue":"6","key":"10.1016\/j.bbadis.2014.10.013_bb0060","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.bbadis.2014.09.011","article-title":"Neuroprotective action of resveratrol","volume":"1852","author":"Bastianetto","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2010.02.054","article-title":"Resveratrol, obesity and diabetes","volume":"635","author":"Szkudelska","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0070","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.bbadis.2014.11.012","article-title":"Resveratrol and obesity: can resveratrol relieve metabolic disturbances?","volume":"1852","author":"De Ligt","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1749-6632.2010.05844.x","article-title":"Anti-diabetic effects of resveratrol","volume":"1215","author":"Szkudelski","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0080","doi-asserted-by":"crossref","first-page":"e19881","DOI":"10.1371\/journal.pone.0019881","article-title":"What is new for an old molecule? Systematic review and recommendations on the use of resveratrol","volume":"6","author":"Vang","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0085","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.lfs.2007.02.002","article-title":"Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats","volume":"80","author":"Chi","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0090","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1248\/bpb.31.897","article-title":"The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats","volume":"31","author":"Silan","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0095","first-page":"81","article-title":"Comparison of effect of resveratrol and vanadium on diabetes related dyslipidemia and hyperglycemia in streptozotocin induced diabetic rats","volume":"1","author":"Shahi","year":"2011","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1423-0127-18-47","article-title":"Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase","volume":"18","author":"Chang","year":"2011","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1507\/endocrj.EJ11-0194","article-title":"Resveratrol prevents streptozotocin-induced diabetes by inhibiting the apoptosis of pancreatic \u03b2-cell and the cleavage of poly (ADP-ribose) polymerase","volume":"59","author":"Ku","year":"2012","journal-title":"Endocr. J."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0110","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4077\/CJP.2012.BAA012","article-title":"Effect of resveratrol on oxidative and inflammatory stress in liver and spleen of streptozotocin-induced type 1 diabetic rats","volume":"55","author":"Chang","year":"2012","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/jmf.2012.2686","article-title":"Resveratrol attenuates early diabetic nephropathy by down-regulating glutathione s-transferases Mu in diabetic rats","volume":"16","author":"Jiang","year":"2013","journal-title":"J. Med. Food"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0120","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.biopha.2008.06.037","article-title":"Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats","volume":"62","author":"Palsamy","year":"2008","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0125","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.cbi.2008.11.008","article-title":"Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats","volume":"179","author":"Palsamy","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/jcp.22138","article-title":"Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats","volume":"224","author":"Palsamy","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0135","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4149\/gpb_2012_039","article-title":"Long-term treatment with resveratrol attenuates oxidative stress pro-inflammatory mediators and apoptosis in streptozotocin-nicotinamide-induced diabetic rats","volume":"31","author":"Soufi","year":"2012","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0140","doi-asserted-by":"crossref","first-page":"537","DOI":"10.33549\/physiolres.930111","article-title":"The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas","volume":"50","author":"Szkudelski","year":"2001","journal-title":"Physiol. Res."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0145","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1258\/ebm.2012.011372","article-title":"Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model","volume":"237","author":"Szkudelski","year":"2012","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0150","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/1753-0407.12072","article-title":"Resveratrol exhibits differential protective effects on fast- and slow-twitch muscles in streptozotocin-induced diabetic rats","volume":"6","author":"Chang","year":"2014","journal-title":"J. Diabetes"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0155","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/BST0360343","article-title":"Oxidative stress: the vulnerable beta-cell","volume":"36","author":"Lenzen","year":"2008","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0160","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s00125-011-2064-1","article-title":"Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes","volume":"54","author":"Lee","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0165","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1152\/ajpendo.00048.2011","article-title":"Resveratrol ameliorates metabolic disorders and muscle wasting in streptozotocin-induced diabetic rats","volume":"301","author":"Chen","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2013.00379","article-title":"Diabetic myopathy: impact of diabetes mellitus on skeletal muscle progenitor cells","volume":"4","author":"D'Souza","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0175","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.2337\/db07-1750","article-title":"Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and \u2013independent pathways","volume":"57","author":"Deng","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0180","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jbt.21432","article-title":"Ameliorative effects of resveratrol on liver injury in streptozotocin-induced diabetic rats","volume":"26","author":"Hamadi","year":"2012","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11010-014-2051-1","article-title":"Redox regulation of antioxidant enzymes: post-translational modulation of catalase and glutathione peroxidase activity by resveratrol in diabetic rat liver","volume":"393","author":"Sadi","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0190","article-title":"Type 2 diabetes as a disease of ectopic fat?","volume":"26","author":"Sattar","year":"2014","journal-title":"BMC Med."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0195","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/dmrr.2513","article-title":"Prevention of type 2 diabetes mellitus: is it feasible?","volume":"30","author":"Palermo","year":"2014","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0200","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.beem.2013.02.004","article-title":"Metabolic complications of obesity","volume":"27","author":"Pedersen","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0205","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.beem.2013.04.012","article-title":"Obesity and weight management in the elderly: a focus on men","volume":"27","author":"Han","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0210","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/nyas.12031","article-title":"Islet \u03b2 cell mass in diabetes and how it relates to function, birth, and death","volume":"1281","author":"Weir","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0215","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1042\/BST0330354","article-title":"Insulin signal transduction in human skeletal muscle: identifying the defects in type II diabetes","volume":"33","author":"Bj\u00f6rnholm","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0220","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.metabol.2011.04.002","article-title":"Resveratrol attenuates high-fat diet-induced insulin resistance by influencing skeletal muscle lipid transport and subsarcolemmal mitochondrial \u03b2-oxidation","volume":"60","author":"Chen","year":"2011","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0225","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.jnutbio.2011.12.003","article-title":"Caveolin-3 is involved in the protection of resveratrol against high-fat-diet-induced insulin resistance by promoting GLUT4 translocation to the plasma membrane in skeletal muscle of ovariectomized rats","volume":"23","author":"Tan","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0230","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.bcp.2011.03.012","article-title":"Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice","volume":"81","author":"Kim","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0235","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.metabol.2011.08.003","article-title":"Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents","volume":"61","author":"Kang","year":"2012","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0240","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.diabres.2012.02.029","article-title":"The protective effect of resveratrol on islet insulin secretion and morphology in mice on a high-fat diet","volume":"97","author":"Zhang","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0245","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.2337\/db11-1498","article-title":"Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet","volume":"61","author":"Jeon","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0250","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.metabol.2014.02.003","article-title":"Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation","volume":"63","author":"Yang","year":"2014","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0255","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2013.10.034","article-title":"Protective effects of chronic resveratrol treatment on vascular inflammatory injury in streptozotocin-induced type 2 diabetic rats: Role of NF-kappa B signaling","volume":"720","author":"Zheng","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0260","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.phrs.2012.05.003","article-title":"Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats","volume":"66","author":"Bagul","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0265","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/archsurg.2011.100","article-title":"Improving glucose metabolism with resveratrol in a swine model of metabolic syndrome through alteration of signaling pathways in the liver and skeletal muscle","volume":"146","author":"Burgess","year":"2011","journal-title":"Arch. Surg."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0270","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.bcp.2008.11.027","article-title":"Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats","volume":"77","author":"Rivera","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0275","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1152\/ajpregu.00200.2013","article-title":"Resveratrol supplementation improves white adipose tissue function in a depot-specific manner in Zucker diabetic fatty rats","volume":"305","author":"Beaudoin","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0280","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1139\/y11-123","article-title":"Effects of resveratrol on the amelioration of insulin resistance in KKAy mice","volume":"90","author":"Chen","year":"2012","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0285","doi-asserted-by":"crossref","first-page":"e50412","DOI":"10.1371\/journal.pone.0050412","article-title":"Chronic resveratrol treatment protects pancreatic islets against oxidative stress in db\/db mice","volume":"7","author":"Lee","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0290","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/1479164113520332","article-title":"Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db\/db mice by inhibiting the NF-\u03baB pathway","volume":"11","author":"Guo","year":"2014","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0295","doi-asserted-by":"crossref","first-page":"e34289","DOI":"10.1371\/journal.pone.0034289","article-title":"Effects of chronic calorie restriction or dietary resveratrol supplementation on insulin sensitivity markers in a primate, Microcebus murinus","volume":"7","author":"Marchal","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0300","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cmet.2013.09.004","article-title":"Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet","volume":"18","author":"Jimenez-Gomez","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0305","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.2337\/db13-0266","article-title":"Resveratrol prevents \u03b2-cell dedifferentiation in nonhuman primates given a high-fat\/high-sugar diet","volume":"62","author":"Fiori","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0310","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/mnfr.201200067","article-title":"Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db\/db mice","volume":"56","author":"Do","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0315","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2337\/db09-0482","article-title":"AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol","volume":"59","author":"Um","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0320","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tem.2012.05.009","article-title":"Role of intramyocelluar lipids in human health","volume":"23","author":"Coen","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0325","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.tem.2012.05.007","article-title":"Muscle mitochondria and insulin resistance: a human perspective","volume":"23","author":"Hoeks","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0330","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4093\/dmj.2013.37.5.315","article-title":"SIRT1 in type 2 diabetes: Mechanisms and therapeutic potential","volume":"37","author":"Kitada","year":"2013","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0335","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2174\/1389450111314060002","article-title":"Sirtuins as possible drug targets in type 2 diabetes","volume":"14","author":"Kitada","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0340","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.bbapap.2009.10.025","article-title":"Biochemical effects of SIRT1 activators","volume":"1804","author":"Baur","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0345","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1172\/JCI67227","article-title":"AMPK, insulin resistance, and the metabolic syndrome","volume":"123","author":"Ruderman","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0350","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1745-7254.2008.00807.x","article-title":"Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase","volume":"29","author":"Shang","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0355","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cmet.2009.11.008","article-title":"Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity","volume":"11","author":"Hoehn","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0360","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2337\/db12-0975","article-title":"High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition","volume":"62","author":"Poulsen","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0365","doi-asserted-by":"crossref","first-page":"525094","DOI":"10.1155\/2011\/525094","article-title":"Distinct effects of calorie restriction and resveratrol on diet-induced obesity and fatty liver formation","volume":"2011","author":"Tauriainen","year":"2011","journal-title":"J. Nutr. Metab."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0370","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.nut.2013.11.016","article-title":"Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation","volume":"30","author":"Andrade","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0375","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.nut.2013.04.014","article-title":"Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats","volume":"29","author":"G\u00f3mez-Zorita","year":"2013","journal-title":"Nutrition"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0380","article-title":"Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice","volume":"12","author":"Zhu","year":"2014","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0385","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.nut.2012.09.011","article-title":"Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet","volume":"29","author":"Alberdi","year":"2013","journal-title":"Nutrition"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0390","doi-asserted-by":"crossref","first-page":"20015","DOI":"10.1074\/jbc.M802187200","article-title":"SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase","volume":"283","author":"Hou","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0395","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4142\/jvs.2014.15.2.179","article-title":"Effects of resveratrol on the insulin signaling pathway of obese mice","volume":"15","author":"Hong","year":"2014","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0400","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/diab.46.1.3","article-title":"Role of fatty acids in the pathogenesis of insulin resistance and NIDDM","volume":"46","author":"Boden","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0405","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/B978-0-12-800101-1.00008-9","article-title":"Free fatty acids and skeletal muscle insulin resistance","volume":"121","author":"Rachek","year":"2014","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0410","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.3390\/ijms15046184","article-title":"Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease","volume":"15","author":"Jung","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0415","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11892-013-0375-y","article-title":"Diabetes mellitus and inflammation","volume":"13","author":"Lontchi-Yimagou","year":"2013","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0420","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/JOE-14-0283","article-title":"The role of adipose tissue immune cells in obesity and low-grade inflammation","volume":"222","author":"Mraz","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0425","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.vph.2012.09.002","article-title":"Phytochemicals and their impact on adipose tissue inflammation and diabetes","volume":"58","author":"Leiherer","year":"2013","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0430","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1113\/jphysiol.2013.259226","article-title":"Submaximal ADP-stimulated respiration is impaired in ZDF rats and recovered by resveratrol","volume":"591","author":"Smith","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0435","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.peptides.2014.03.006","article-title":"Cross talk between angiotensin-(1-7)\/Mas axis and sirtuins in adipose tissue and metabolism of high-fat feed mice","volume":"55","author":"Oliveira Andrade","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0440","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1017\/S0007114511000316","article-title":"Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients","volume":"106","author":"Brasny\u00f3","year":"2011","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0445","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cmet.2011.10.002","article-title":"Calorie restriction-like effects of 30days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans","volume":"14","author":"Timmers","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0450","doi-asserted-by":"crossref","first-page":"851267","DOI":"10.1155\/2013\/851267","article-title":"Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients","volume":"2013","author":"Movahed","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0455","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.nutres.2012.06.003","article-title":"Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus","volume":"32","author":"Bhatt","year":"2012","journal-title":"Nutr. Res."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0460","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/gerona\/glr235","article-title":"Pilot study of resveratrol in older adults with impaired glucose tolerance","volume":"67","author":"Crandall","year":"2012","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0465","article-title":"Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion","volume":"19","author":"M\u00e9ndez-Del Villar","year":"2014","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0470","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1161\/ATVBAHA.113.302342","article-title":"High-dose resveratrol treatment for 2weeks inhibits intestinal and hepatic lipoprotein production in overweight\/obese men","volume":"33","author":"Dash","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0475","article-title":"Resveratrol promotes foot ulcer size reduction in type 2 diabetes patients","volume":"20","author":"Bashmakov","year":"2014","journal-title":"ISRN Endocrinol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0480","article-title":"Resveratrol does not benefit patients with nonalcoholic fatty liver disease","volume":"25","author":"Chachay","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0485","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1113\/jphysiol.2013.270256","article-title":"Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men","volume":"592","author":"Olesen","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0490","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cmet.2012.09.015","article-title":"Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance","volume":"16","author":"Yoshino","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0495","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1123\/ijsnem.2013-0045","article-title":"Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure","volume":"24","author":"Goh","year":"2014","journal-title":"Int. J. Sport Nutr. Exerc. Metab."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0500","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1113\/jphysiol.2004.064881","article-title":"Plasticity of the beta cell insulin secretory competence: preparing the pancreatic beta cell for the next meal","volume":"558","author":"Hinke","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0505","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0168-8227(11)70010-9","article-title":"The dual control of insulin secretion by glucose involves triggering and amplifying pathways in \u03b2-cells","volume":"93","author":"Henquin","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0510","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-62703-068-7_9","article-title":"The GK rat: a prototype for the study of non-overweight type 2 diabetes","volume":"933","author":"Portha","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0515","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.biocel.2005.09.007","article-title":"Animal models of type 2 diabetes with reduced pancreatic beta-cell mass","volume":"38","author":"Masiello","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2012.08.003","article-title":"The molecular mechanisms of pancreatic \u03b2-cell glucotoxicity: recent findings and future research directions","volume":"364","author":"Bensellam","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0525","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/978-1-4614-5441-0_22","article-title":"The pancreatic beta cells in human type 2 diabetes","volume":"771","author":"Marchetti","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0530","article-title":"Resveratrol supplementation restores high-fat diet-induced insulin secretion dysfunction by increasing mitochondrial function in islet","volume":"15","author":"Kong","year":"2014","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0535","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/diabetes.53.2007.S136","article-title":"Uncoupling protein 2 and islet function","volume":"53","author":"Chan","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2014.10.013_bb0540","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/740849","article-title":"Mitochondrial hormesis in pancreatic \u03b2 cells: does uncoupling protein 2 play a role?","author":"Li","year":"2012","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0545","doi-asserted-by":"crossref","first-page":"73","DOI":"10.33549\/physiolres.932633","article-title":"Antioxidant and regulatory role of mitochondrial uncoupling protein UCP2 in pancreatic beta-cells","volume":"63","author":"Je\u017eek","year":"2014","journal-title":"Physiol. Res."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0550","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/dme.12231","article-title":"Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects","volume":"30","author":"Knop","year":"2013","journal-title":"Diabet. Med."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0555","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2012.04.003","article-title":"SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function","volume":"15","author":"Price","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0560","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1152\/ajpcell.00357.2013","article-title":"Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1\u03b1 axis","volume":"307","author":"Ljubicic","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbadis.2014.10.013_bb0565","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/mnfr.201200589","article-title":"Reviev of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans","volume":"58","author":"Cottart","year":"2014","journal-title":"Mol. Nutr. Food Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443914003196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443914003196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T15:45:07Z","timestamp":1746459907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443914003196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":113,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0925443914003196"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2014.10.013","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resveratrol and diabetes: from animal to human studies","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2014.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}